Critical Care

OCEAN(a)-DOSE (olpasiran 10 mg)

Study

OCEAN(a)-DOSE (olpasiran 225 mg every 12 weeks)

Study

OCEAN(a)-DOSE (olpasiran 225 mg every 24 weeks)

Study

OCEAN(a)-DOSE (olpasiran 75 mg)

Study

OLV in Thoracic Anesthesia

Study

ONCO PE

Study

Ondansetron

Drug

Ondansetron hydrochloride

Drug

ONTARGET (telmisartan with ramipril)

Study

ONTARGET (telmisartan)

Study

OPTIMAL-BP

Study

OPTIMAS

Study

OPTPRESS

Study

Oral Care Program for Postextubation Dysphagia

Study

ORIGINAL

Study

OSCILLATE

Study

Osmolality, increased

Finding

Ovarian hyperstimulation syndrome

Disease

Oxy-PICU

Study

Oxygen-ICU

Study